Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling studyResearch in context

Summary: Background: The most recent updated hypertension guidelines recommend individuals with systolic blood pressure (SBP)/diastolic blood pressure (DBP) of 130–139/80–89 mmHg and high cardiovascular risk should receive antihypertensive drug treatment. This study aimed to assess the benefits and...

Full description

Bibliographic Details
Main Authors: Jiangtao Li, Dong Zhao, Jun Cai, Shuohua Chen, Shouling Wu, Yue Qi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606523002808